Is this you? Create Your Porfile
Avatar

Gerd Müller

Schering AG

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Gerd Müller is active.

Explore More

Publication

Featured researches published by Gerd Müller.

Archive | 2000

Ent-steroids as selectively active estrogens

Siegfried Schwarz; Dirk Kosemund; Gerd Müller; Margit Richter; Olaf Peters; Peter Droescher; Walter Elger; Alexander Hillisch; Ulf Bömer; Karl-Heinrich Fritzemeier; Christa Hegele-Hartung

Archive | 2000

C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds

Sigfrid Schwarz; Gerd Müller; Dirk Kosemund; Margit Richter; Olaf Peters; Ina Scherlitz-Hofmann; Thomas Michel; Walter Elger; Gudrun Reddersen; Birgitt Schneider

Archive | 1991

Process for the production of unsaturated 17 alpha -cyanomethyl-17 beta -hydroxy steroids

Gerhard Teichmuller; Gerd Müller

Archive | 2001

19-nor-17α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ring

Gerd Müller; Uwe Kollenkirchen; Dirk Kosemund; Karl-Heinrich Fritzemeier; Walter Elger

Archive | 1996

17α-cyanomethylestra-4,9-dien derivatives and pharmaceutical compositions containing same

Gerhard Teichmüller; Gerd Müller; Sigfrid Schwarz; Bernd Undeutsch; Harry Henkel; Ronald Gebühr; Günter Kaufmann; Doris Hübler; Michael Oettel

Archive | 1991

Process for the production of unsaturated 17 α-cyanomethyl-17 β-h

Gerhard Teichmuller; Gerd Müller

Archive | 2002

Estrogen receptor beta-selective agonists for anti-catabolic therapy in an aging organism

Walter Elger; Alexander Hillisch; Dirk Kosemund; Gerd Müller; Olaf Peters; Gudrun Reddersen; Birgitt Schneider

Archive | 2003

Therapeutic use of estrogen receptor (ER)beta-selective agonists for triggering somatotropic, organotropic and anticatabolic effects (somatotropic therapy)

Walter Elger; Gudrun Reddersen; Birgitt Schneider; Alexander Hillisch; Olaf Peters; Dirk Kosemund; Gerd Müller

Archive | 1998

NEUE 17ALPHA-CYANOMETHYLESTRA-4,9-DIEN-DERIVATE, VERFAHREN ZU IHRER HERSTELLUNG UND DIESE VERBINDUNGEN ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN

Ronald Gebühr; Harry Henkel; Doris Hübler; Günter Kaufmann; Gerd Müller; Michael Oettel; Sigfrid Schwarz; Gerhard Teichmüller; Bernd Undeutsch

Archive | 1996

New 17alpha-Cyanomethylestra-4,9-dien-derivatives, a process for the production of these compounds and pharmaceutical compositions containing them

Gerhard Teichmüller; Gerd Müller; Sigfrid Schwarz; Bernd Undeutsch; Harry Henkel; Ronald Gebühr; Günter Kaufmann; Doris Hübler; Michael Oettel

Explore More

Collaboration

Dive into the Gerd Müller's collaboration.

Top Co-Authors
Avatar

Dirk Kosemund

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Sigfrid Schwarz

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Walter Elger

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Doris Hübler

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Günter Kaufmann

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Michael Oettel

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Olaf Peters

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Alexander Hillisch

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Birgitt Schneider

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Gudrun Reddersen

Schering AG

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge